Telomerase and human tumorigenesis

Seminars in Cancer Biology

Volumn 10, Issue 6, 2000, Pages 399-406

  Stewart, Sheila A ^a   Weinberg, Robert A ^a,b  

^a WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Crisis; Senescence; Telomerase; Telomere

Indexed keywords

CELL DNA; DNA POLYMERASE; PROTEIN P53; RETINOBLASTOMA PROTEIN; TELOMERASE;

CARCINOGENESIS; CELL AGING; CELL DEATH; CELL IMMORTALIZATION; CELL PROLIFERATION; CELL SURVIVAL; DNA REPLICATION; ENZYME ACTIVATION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; REVIEW; TELOMERE;

EID: 0034472472     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1006/scbi.2000.0339     Document Type: Article

References (59)

1. Telomere length predicts replicative capacity of human fibroblasts
2. Structure of HIV-1 reverse transcriptase/DNA complex at 7 A resolution showing active site locations
3. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA
4. Extension of life-span by introduction of telomerase into normal human cells
5. Telomere elongation in immortal human cells without detectable telomerase activity
6. The telomere lengthening mechanism in telomerase-negative immortal human cells does not involve the telomerase RNA subunit
7. Limited lifespan in somatic cell hybrids and cybrids
8. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis
9. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity
10. Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization
11. Crystal structure of the ribonuclease H domain of HIV-1 reverse transcriptase
12. Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics
13. Replicative senescence: The human fibroblast comes of age
14. Short dysfunctional telomeres impair tumorigenesis in the INK4a(delta2/3) cancer-prone mouse
15. Telomeres, telomerase and cancer
16. Creation of human tumour cells with defined genetic elements
17. Inhibition of telomerase limits the growth of human cancer cells
18. The hallmarks of cancer
19. Telomere length dynamics and chromosomal instability in cells derived from telomerase null mice
20. Telomeres shorten during ageing of human fibroblasts
21. Telomerase, cell immortality, and cancer
22. The telomere hypothesis of cellular aging
23. The serial cultivation of human diploid cell strains
24. Tumor spectrum analysis in p53-mutant mice
25. Molecular mechanisms of DNA double strand break repair
26. Specific association of human telomerase activity with immortal cells and cancer
27. Telomere structure and telomerase expression during mouse development and tumorigenesis
28. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells
29. Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor
30. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
31. RAD50 and RAD51 define two pathways that collaborate to maintain telomeres in the absence of telomerase
32. Essential role of mouse telomerase in highly proliferative organs
33. p53, the cellular gatekeeper for growth and division
34. Telomerase and DNA end replication: No longer a lagging strand problem?
35. Reverse transcriptase motifs in the catalytic subunit of telomerase
36. An alternative pathway for yeast telomere maintenance rescues est1-senescence
37. Accumulation of short telomeres in human fibroblasts prior to replicative senescence
38. Cap-prevented recombination between terminal telomeric repeat arrays (telomere CPR) maintains telomeres in Kluyveromyces lactis lacking telomerase
39. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization
40. Two modes of survival of fission yeast without telomerase
41. Telomerase catalytic subunit homologs from fission yeast and human
42. Dominance of the senescent phenotype in heterokaryons between replicative and post-replicative human fibroblast-like cells
43. Evidence for the recessive nature of cellular immortality
44. Longevity, stress response, and cancer in aging telomerase-deficient mice
45. A telomere-independent senescence mechanism is the sole barrier to Syrian hamster cell immortalization
46. The relationship between in vitro cellular aging and in vivo human age
47. The INK4a/ARF locus in murine tumorigenesis
48. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
49. A survey of telomerase activity in human cancer
50. Defining the molecular mechanisms of human cell immortalization
51. The ARF/p53 pathway
52. Telomere-telomere recombination is an efficient bypass pathway for telomere maintenance in Saccharomyces cerevisiae
53. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span
54. Evidence for a mitotic clock in human hematopoietic stem cells: Loss of telomeric DNA with age
55. Expression of catalytically active telomerase does not prevent premature senescence caused by overexpression of oncogenic Ha-Ras in normal human fibroblasts
56. Correlation between senescence and DNA repair in cells from young and old individuals and in premature aging syndromes
57. Human endothelial cell life extension by telomerase expression
58. Telomere shortening and apoptosis in telomerase-inhihited human tumor cells
59. Telomerase extends the lifespan of virus-transformed human cells without net telomere lengthening